"We believe that employers, payers and pharmaceutical companies see tremendous value in the combination of Dario and Twill as an integrated offering to help solve the urgent challenges of GLP-1 management. In fact, we expect at least ten of our employer clients to adopt our integrated offering in the next quarter or so to leverage the power of our enhanced multi-chronic condition platform." To view the full press release, visit https://ibn.fm/gO2NT About DarioHealth Corp. DarioHealth is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Its platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health.